Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tyring

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Infectious Diseases|July 23, 2002
Detection of antibodies to human immunodeficiency virus (HIV) that recognize conformational epitopes of glycoproteins 160 and 41 often allows for early diagnosis of HIV infectionJianmin Chen, Liqiang Wang, Jenny J-Y Chen, et al.
Eclinicalmedicine|February 23, 2023
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a studyHoward Sofen, Robert Bissonnette, Gil Yosipovitch, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 17, 2004
Biopterin responsive phenylalanine hydroxylase deficiencyReuben Matalon, Richard Koch, Kimberlee Michals-Matalon, et al.
The Journal of Infectious Diseases|April 4, 2002
Is human immunodeficiency virus RNA load composed of neutralized immune complexes?Ferdinando Dianzani, Guido Antonelli, Elisabetta Riva, et al.
The New England Journal of Medicine|February 10, 2021
Phase 3 Trials of Tirbanibulin Ointment for Actinic KeratosisAndrew Blauvelt, Steven Kempers, Edward Lain, et al.
Archives of Dermatology|January 20, 2010
Disfiguring generalized verrucosis in an indonesian man with idiopathic CD4 lymphopeniaBachti Alisjahbana, Rachmat Dinata, Endang Sutedja, et al.
Journal of the American Academy of Dermatology|September 25, 2016
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR studyAndrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, et al.
The Journal of Infectious Diseases|March 23, 2017
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized TrialDavid I Bernstein, Anna Wald, Terri Warren, et al.
Dermatologic Therapy|December 26, 2021
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trialBardur Sigurgeirsson, John Browning, Stephen Tyring, et al.
The New England Journal of Medicine|November 22, 2002
Glycoprotein-D-adjuvant vaccine to prevent genital herpesLawrence R Stanberry, Spotswood L Spruance, Anthony L Cunningham, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Infectious Diseases|July 23, 2002
Detection of antibodies to human immunodeficiency virus (HIV) that recognize conformational epitopes of glycoproteins 160 and 41 often allows for early diagnosis of HIV infectionJianmin Chen, Liqiang Wang, Jenny J-Y Chen, et al.
Eclinicalmedicine|February 23, 2023
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a studyHoward Sofen, Robert Bissonnette, Gil Yosipovitch, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 17, 2004
Biopterin responsive phenylalanine hydroxylase deficiencyReuben Matalon, Richard Koch, Kimberlee Michals-Matalon, et al.
The Journal of Infectious Diseases|April 4, 2002
Is human immunodeficiency virus RNA load composed of neutralized immune complexes?Ferdinando Dianzani, Guido Antonelli, Elisabetta Riva, et al.
The New England Journal of Medicine|February 10, 2021
Phase 3 Trials of Tirbanibulin Ointment for Actinic KeratosisAndrew Blauvelt, Steven Kempers, Edward Lain, et al.
Archives of Dermatology|January 20, 2010
Disfiguring generalized verrucosis in an indonesian man with idiopathic CD4 lymphopeniaBachti Alisjahbana, Rachmat Dinata, Endang Sutedja, et al.
Journal of the American Academy of Dermatology|September 25, 2016
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR studyAndrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, et al.
The Journal of Infectious Diseases|March 23, 2017
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized TrialDavid I Bernstein, Anna Wald, Terri Warren, et al.
Dermatologic Therapy|December 26, 2021
Secukinumab demonstrates efficacy, safety, and tolerability upon administration by 2 ml autoinjector in adult patients with plaque psoriasis: 52-week results from MATURE, a randomized, placebo-controlled trialBardur Sigurgeirsson, John Browning, Stephen Tyring, et al.
The New England Journal of Medicine|November 22, 2002
Glycoprotein-D-adjuvant vaccine to prevent genital herpesLawrence R Stanberry, Spotswood L Spruance, Anthony L Cunningham, et al.
Pageof 13